---
figid: PMC10147314__IJO-62-5-05513-g01
figtitle: NEDD8 regulates the ubiquitin-proteasome degradation pathways related to
  CRL and MDM2, and it realizes the regulation of proteins by promoting the NFKB,
  PI3K/AKT/mTOR, Hippo-YAP and receptor tyrosine kinase signaling pathways
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10147314
filename: PMC10147314__IJO-62-5-05513-g01.jpg
figlink: /pmc/articles/PMC10147314/figure/F2
number: F2
caption: NEDD8 regulates the ubiquitin-proteasome degradation pathways related to
  CRL and MDM2, and it realizes the regulation of proteins by promoting the NF-κB,
  PI3K/AKT/mTOR, Hippo-YAP and receptor tyrosine kinase signaling pathways. NEDD8
  also inhibits MDM2-p53, HIF and other signaling pathways, which in turn affects
  DNA damage repair, the cell cycle and tumor development. HIF, hypoxia-inducible
  factor; CRL, cullin-ring ligase; EMT, epithelial to mesenchymal transition; NEDD8,
  neural precursor cell expressed developmentally downregulated 8; NAE, NEDD8-activating
  enzyme; NEDP1, NEDD8 protease 1; CSN, constitutive photomorphogenesis signalosome;
  PTEN, phosphatase and tensin homolog; VHL, von Hippel-Lindau; Mst1/2, mammalian
  sterile 20-like kinase 1/2; YAP, Yes-associated protein; MDM2, murine double minute
  2; PI3K, phosphatidylinositol-3-kinase; AKT, protein kinase B; mTOR, mammalian target
  of rapamycin; LATS1/2, large tumor suppressor homolog 1/2; EGFR, epidermal growth
  factor receptor; TGFβRII, TGF-β type II receptor.
papertitle: Targeting neddylation as a novel approach to lung cancer treatment (Review)
reftext: Zhaochun Tian, et al. Int J Oncol. 2023 May;62(5).
year: '2023'
doi: 10.3892/ijo.2023.5513
journal_title: International Journal of Oncology
journal_nlm_ta: Int J Oncol
publisher_name: D.A. Spandidos
keywords: neddylation | lung cancer | MLN4924 | NEDD8 | signaling pathway | treatment
automl_pathway: 0.9141748
figid_alias: PMC10147314__F2
figtype: Figure
redirect_from: /figures/PMC10147314__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10147314__IJO-62-5-05513-g01.html
  '@type': Dataset
  description: NEDD8 regulates the ubiquitin-proteasome degradation pathways related
    to CRL and MDM2, and it realizes the regulation of proteins by promoting the NF-κB,
    PI3K/AKT/mTOR, Hippo-YAP and receptor tyrosine kinase signaling pathways. NEDD8
    also inhibits MDM2-p53, HIF and other signaling pathways, which in turn affects
    DNA damage repair, the cell cycle and tumor development. HIF, hypoxia-inducible
    factor; CRL, cullin-ring ligase; EMT, epithelial to mesenchymal transition; NEDD8,
    neural precursor cell expressed developmentally downregulated 8; NAE, NEDD8-activating
    enzyme; NEDP1, NEDD8 protease 1; CSN, constitutive photomorphogenesis signalosome;
    PTEN, phosphatase and tensin homolog; VHL, von Hippel-Lindau; Mst1/2, mammalian
    sterile 20-like kinase 1/2; YAP, Yes-associated protein; MDM2, murine double minute
    2; PI3K, phosphatidylinositol-3-kinase; AKT, protein kinase B; mTOR, mammalian
    target of rapamycin; LATS1/2, large tumor suppressor homolog 1/2; EGFR, epidermal
    growth factor receptor; TGFβRII, TGF-β type II receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TP53
  - TP63
  - TP73
  - MTOR
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - MDM2
  - EGFR
  - NEDD8
  - PTEN
  - TGFB1
  - TGFB2
  - TGFB3
  - IL31RA
  - HIF1A
  - EPAS1
  - HIF3A
  - ARNT
  - ARNT2
  - BMAL1
  - VHL
  - LATS1
  - LATS2
  - NFKB1
  - ITK
  - SLC22A3
  - CRL
---
